Prevalence of diabetes in relation to ISP levels and BMI
| BMI (kg/m2) | All men | |||||
|---|---|---|---|---|---|---|
| <25 | 25–29.9 | ≥30 | ||||
| n | 3,297 | 2,318 | 435 | 6,050 | ||
| Men with diabetes (n) | 118 | 130 | 73 | 321 | ||
| Fibrinogen Q1–3 vs. Q4 (% with diabetes) | 3.4 vs. 4.2 | 4.8 vs. 7.8 | 14.2 vs. 21.6 | 4.6 vs. 7.3 | ||
| Haptoglobin Q1–3 vs. Q4 (% with diabetes) | 3.7 vs. 3.2 | 4.7 vs. 8.4 | 14.8 vs. 21.6 | 4.8 vs. 6.7 | ||
| Ceruloplasmin Q1–3 vs. Q4 (% with diabetes) | 3.4 vs. 4.2 | 5.3 vs. 6.7 | 16.3 vs. 18.4 | 5.0 vs. 6.3 | ||
| Orosomucoid Q1–3 vs. Q4 (% with diabetes) | 3.9 vs. 2.7 | 5.1 vs. 6.9 | 14.6 vs. 20.9 | 5.0 vs. 6.1 | ||
| α1-Antitrypsin Q1–3 vs. Q4 (% with diabetes) | 3.4 vs. 3.9 | 5.4 vs. 6.2 | 15.9 vs. 19.2 | 5.1 vs. 5.8 | ||
| No ISP in top Q (% with diabetes, n/n) | 3.3 (45/1,373) | 3.8 (35/930) | 13.9 (19/137) | 4.1 (99/2,440) | ||
| One ISP in top Q (% with diabetes, n/n) | 4.0 (33/816) | 6.3 (39/621) | 12.8 (15/117) | 5.6 (87/1,554) | ||
| Two ISPs in top Q (% with diabetes, n/n) | 3.3 (16/490) | 6.7 (23/341) | 20.8 (15/72) | 6.0 (54/903) | ||
| Three ISPs in top Q (% with diabetes, n/n) | 5.4 (16/299) | 6.9 (16/231) | 16.9 (10/59) | 7.1 (42/589) | ||
| Four or five ISPs in top Q (% with diabetes, n/n) | 2.5 (8/319) | 8.7 (17/195) | 28.0 (14/50) | 6.9 (39/564) | ||
| Zero to one ISP in top Q (% with diabetes) | 3.6 | 4.8 | 13.4 | 4.7 | ||
| Two to five ISPs in top Q (% with diabetes) | 3.6 | 7.3 | 21.5 | 6.6 | ||
| Adjusted OR for diabetes in men with two to five ISPs* | 1.09 (0.72–1.6) | 1.64 (1.13–2.4) | 1.74 (1.03–3.0) | 1.39 (1.09–1.77) | ||
* Adjusted for age, physical activity, smoking, and BMI (all men only). OR, odds ratio; Q, quartile.